DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC)
CUSIP: 25253X207
Q2 2021 13F Holders as of 30 Jun 2021
- Type / Class
- Equity / Voting Common Shares, no par value
- Shares outstanding
- 52,272,727
- Total 13F shares
- 3,783,974
- Share change
- -1,910,088
- Total reported value
- $16,902,446
- Put/Call ratio
- 714%
- Price per share
- $4.45
- Number of holders
- 38
- Value change
- -$48,644,584
- Number of buys
- 21
- Number of sells
- 16
Quarterly Holders Quick Answers
What is CUSIP 25253X207?
CUSIP 25253X207 identifies DMAC - DiaMedica Therapeutics Inc. - Voting Common Shares, no par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 25253X207:
Top shareholders of DMAC - DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Dorsey Wright & Associates |
13F
|
Company |
0.01%
|
3,937
|
$36,024,000 | — | 31 Mar 2021 | |
| Stonepine Capital Management, LLC |
13F
|
Company |
2%
|
1,023,409
|
$9,364,000 | — | 31 Mar 2021 | |
| Corriente Advisors, LLC |
13F
|
Company |
1.7%
|
870,228
|
$7,963,000 | — | 31 Mar 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.6%
|
846,266
|
$7,744,000 | — | 31 Mar 2021 | |
| Manatuck Hill Partners, LLC |
13F
|
Company |
1.1%
|
570,500
|
$5,220,000 | — | 31 Mar 2021 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
1.1%
|
552,250
|
$5,053,000 | — | 31 Mar 2021 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.79%
|
415,000
|
$3,797,000 | — | 31 Mar 2021 | |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC |
13F
|
Company |
0.35%
|
185,000
|
$1,693,000 | — | 31 Mar 2021 | |
| Granite Point Capital Management, L.P. |
13F
|
Company |
0.35%
|
184,380
|
$1,687,000 | — | 31 Mar 2021 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.29%
|
153,100
|
$1,401,000 | — | 31 Mar 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.25%
|
128,468
|
$1,175,000 | — | 31 Mar 2021 | |
| Informed Momentum Co LLC |
13F
|
Company |
0.21%
|
108,232
|
$990,000 | — | 31 Mar 2021 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.2%
|
104,524
|
$982,000 | — | 31 Mar 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.16%
|
85,026
|
$778,000 | — | 31 Mar 2021 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.15%
|
75,967
|
$695,000 | — | 31 Mar 2021 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.13%
|
70,281
|
$643,000 | — | 31 Mar 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.12%
|
60,165
|
$551,000 | — | 31 Mar 2021 | |
| Leon G. Cooperman |
13F
|
Individual |
0.1%
|
50,000
|
$458,000 | — | 31 Mar 2021 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.09%
|
46,562
|
$426,000 | — | 31 Mar 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.08%
|
40,576
|
$371,000 | — | 31 Mar 2021 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.07%
|
35,536
|
$325,000 | — | 31 Mar 2021 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.04%
|
20,601
|
$189,000 | — | 31 Mar 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0.04%
|
19,425
|
$178,000 | — | 31 Mar 2021 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.02%
|
10,700
|
$98,000 | — | 31 Mar 2021 | |
| Patriot Financial Group Insurance Agency, LLC |
13F
|
Company |
0.02%
|
9,203
|
$84,000 | — | 31 Mar 2021 | |
| Federation Des Caisses Desjardins du Quebec |
13F
|
Individual |
0.01%
|
6,030
|
$55,175 | — | 31 Mar 2021 | |
| Valeo Financial Advisors, LLC |
13F
|
Company |
0.01%
|
5,000
|
$46,000 | — | 31 Mar 2021 | |
| US BANCORP \DE\ |
13F
|
Company |
0.01%
|
4,335
|
$40,000 | — | 31 Mar 2021 | |
| BARCLAYS PLC |
13F
|
Company |
0.01%
|
3,412
|
$31,000 | — | 31 Mar 2021 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
1,805
|
$17,000 | — | 31 Mar 2021 | |
| UBS Group AG |
13F
|
Company |
0%
|
1,050
|
$10,000 | — | 31 Mar 2021 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
910
|
$8,000 | — | 31 Mar 2021 | |
| Credential Qtrade Securities Inc. |
13F
|
Company |
0%
|
769
|
$7,036 | — | 31 Mar 2021 | |
| GABLES CAPITAL MANAGEMENT INC. |
13F
|
Company |
0%
|
542
|
$5,000 | — | 31 Mar 2021 | |
| Newbridge Financial Services Group, Inc. |
13F
|
Company |
0%
|
513
|
$5,000 | — | 31 Mar 2021 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0%
|
285
|
$3,000 | — | 31 Mar 2021 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0%
|
254
|
$2,000 | — | 31 Mar 2021 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
106
|
$1,000 | — | 31 Mar 2021 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
68
|
$1,000 | — | 31 Mar 2021 | |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC |
13F
|
Company |
0%
|
65
|
$1,000 | — | 31 Mar 2021 |
Institutional Holders of DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC) as of Q2 2021
As of 30 Jun 2021,
DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC) was held by
38 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,783,974 shares.
The largest 10 holders included
VANGUARD GROUP INC, Manatuck Hill Partners, LLC, Stonepine Capital Management, LLC, Ikarian Capital, LLC, JACOB ASSET MANAGEMENT OF NEW YORK LLC, Corriente Advisors, LLC, MARSHALL WACE, LLP, BANK OF MONTREAL /CAN/, GEODE CAPITAL MANAGEMENT, LLC, and RENAISSANCE TECHNOLOGIES LLC.
This page lists
38
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2021 vs Q1 2021 Across Filers
Q1 2021 holders
38
Q2 2021 holders
38
Holder diff
0
| Investor | Q1 2021 Shares | Q2 2021 Shares | Share Diff | Share Chg % | Q1 2021 Value $ | Q2 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.